{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:51:09Z","timestamp":1786992669426,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,19]],"date-time":"2026-12-19T00:00:00Z","timestamp":1797638400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jiac.2025.102898","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T05:26:42Z","timestamp":1766122002000},"page":"102898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The effect of pharmacist-led antimicrobial stewardship on antimicrobial use in an intensive care unit: a single-center, retrospective, observational study"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-4443","authenticated-orcid":false,"given":"Yoshihiro","family":"Nishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Iinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Togen","family":"Masauji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102898_bib1","series-title":"The review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations","author":"O'Neill","year":"2016"},{"key":"10.1016\/j.jiac.2025.102898_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13756-019-0471-0","article-title":"Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review","volume":"8","author":"Nathwani","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"issue":"3","key":"10.1016\/j.jiac.2025.102898_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/ajhp\/57.3.268","article-title":"Outcomes of an antimicrobial control program in a teaching hospital","volume":"57","author":"Gentry","year":"2000","journal-title":"Am J Health Syst Pharm"},{"issue":"23","key":"10.1016\/j.jiac.2025.102898_bib4","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","article-title":"Time to treatment and mortality during mandated emergency care for sepsis","volume":"376","author":"Seymour","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jiac.2025.102898_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2899","article-title":"CDC prevention epicenters program. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jiac.2025.102898_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Cooperative Antimicrobial Therapy of Septic Shock Database Research group. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.jiac.2025.102898_bib7","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1001\/jama.2009.1754","article-title":"International study of the prevalence and outcomes of infection in intensive care units","volume":"302","author":"Vincent","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2025.102898_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/519178","article-title":"Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital","volume":"28","author":"Chang","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2025.102898_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","article-title":"Infectious Diseases Society of America and the Society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship","volume":"44","author":"Dellit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiac.2025.102898_bib10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archinte.163.8.972","article-title":"Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity","volume":"163","author":"Hecker","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2025.102898_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/591126","article-title":"Emergency department visits for antibiotic-associated adverse events","volume":"47","author":"Shehab","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102898_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/QCO.0b013e32832d52e0","article-title":"Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings","volume":"22","author":"Tacconelli","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"27","key":"10.1016\/j.jiac.2025.102898_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016261","article-title":"Mortality rate and other clinical features observed in open vs closed format intensive care units: a systematic review and meta-analysis","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jiac.2025.102898_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1263618","article-title":"Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study","volume":"14","author":"Yu","year":"2023","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.jiac.2025.102898_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ajic.2017.02.021","article-title":"Pharmacist-driven antimicrobial stewardship in intensive care units in East China: a multicenter prospective cohort study","volume":"45","author":"Li","year":"2017","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.jiac.2025.102898_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/1120009X.2022.2087652","article-title":"Impact of ward pharmacist-led antimicrobial stewardship in intensive care units","volume":"35","author":"Hashimoto","year":"2023","journal-title":"J Chemother"},{"issue":"8","key":"10.1016\/j.jiac.2025.102898_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2025.102898_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhin.2025.06.005","article-title":"Long-term effect of carbapenem preauthorization: an interrupted time-series study over 20 years","volume":"162","author":"Urakami","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiac.2025.102898_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jhin.2024.03.006","article-title":"Antibiotic management programme in a tertiary intensive care unit: effects of a carbapenem-restricted period on clinical and laboratory parameters and costs of infections","volume":"148","author":"Asilt\u00fcrk","year":"2024","journal-title":"J Hosp Infect"},{"issue":"3","key":"10.1016\/j.jiac.2025.102898_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3918\/jsicm.27_244","article-title":"Position paper on critical care pharmacists in Japan","volume":"27","year":"2020","journal-title":"J Jpn Soc Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jiac.2025.102898_bib21","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1097\/CCM.0000000000004437","article-title":"Position paper on critical care pharmacy services: 2020 update","volume":"48","author":"Lat","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2025.102898_bib22","article-title":"Antibiotic use for empirical therapy in the critical care units in primary and secondary hospitals in Vietnam: a multicenter cross-sectional study","volume":"18","author":"Dat","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"11","key":"10.1016\/j.jiac.2025.102898_bib23","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1097\/CCM.0000000000005090","article-title":"Likelihood of bacterial infection in patients treated with broad-spectrum IV antibiotics in the emergency department","volume":"49","author":"Shappell","year":"2021","journal-title":"Crit Care Med"},{"issue":"25","key":"10.1016\/j.jiac.2025.102898_bib24","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance","volume":"101","author":"Harbarth","year":"2000","journal-title":"Circulation"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500296X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X2500296X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:07:54Z","timestamp":1767859674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X2500296X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1341321X2500296X"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102898","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of pharmacist-led antimicrobial stewardship on antimicrobial use in an intensive care unit: a single-center, retrospective, observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102898"}}